Sorry, you need to enable JavaScript to visit this website.

If you have a question on COVID-19 mRNA Vaccine BNT162b2 click here.

This medicinal product has been given authorisation for temporary supply by the UK Department of Health and Social Care and the Medicines & Healthcare products Regulatory Agency. It does not have a marketing authorisation, but this temporary authorisation grants permission for the medicine to be used for active immunization to prevent COVID-19 disease caused by SARS-CoV-2 virus in individuals aged 16 years of age and over.

As with any new medicine in the UK, this product will be closely monitored to allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Still Need Help?... Contact Us
Pfizer Medical Information Medical Inquiry Icon
Receive responses to questions through phone or email.
Pfizer Medical Information Call Icon
Call
01304 616161
Speak live with a Pfizer Medical Information professional regarding your medical question or to report an adverse event from Monday to Friday between 09:00 AM and 17:00 PM.
Pfizer Medical Information Chat Icon

Chat online with Pfizer Medical Information regarding your enquiry on a Pfizer medicine.

Recent Announcements

No current announcement
Pfizer Medical Information Professional Resources Icon
Access to a variety of links including available grant programs and the Pfizer Pipeline.
Pfizer Medical Information Clinical Trials Icon
Access to information on clinical trials for a range of diseases and conditions.
Pfizer Medical Information Patient Assistant Icon
Access resources for your patient’s health and general information on our products and company.